488
Participants
Start Date
October 31, 2011
Primary Completion Date
April 22, 2013
Study Completion Date
December 26, 2016
dolutegravir 50 mg OAD
1 x 50 mg tablet OAD
darunavir 800mg OAD
2 x 400mg tablets OAD
ritonavir 100mg OAD
1 x 100mg tablet OAD
GSK Investigational Site, Lausanne
GSK Investigational Site, Bern
GSK Investigational Site, Turin
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Madrid
GSK Investigational Site, Charlotte
GSK Investigational Site, Decatur
GSK Investigational Site, Augusta
GSK Investigational Site, Macon
GSK Investigational Site, Savannah
GSK Investigational Site, Daytona Beach
GSK Investigational Site, Vero Beach
GSK Investigational Site, Orlando
GSK Investigational Site, Tampa
GSK Investigational Site, Montpellier
GSK Investigational Site, Birmingham
GSK Investigational Site, Seville
GSK Investigational Site, Modena
GSK Investigational Site, Nantes
GSK Investigational Site, Cincinnati
GSK Investigational Site, Detroit
GSK Investigational Site, Minneapolis
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Kansas City
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Longview
GSK Investigational Site, Paris
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Aurora
GSK Investigational Site, Denver
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Saint-Denis
GSK Investigational Site, Portland
GSK Investigational Site, Seattle
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Krasnodar
GSK Investigational Site, Volgograd
GSK Investigational Site, Saratov
GSK Investigational Site, Constanța
GSK Investigational Site, Norwalk
GSK Investigational Site, Springfield
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Providence
GSK Investigational Site, Rome
GSK Investigational Site, Ponce
GSK Investigational Site, San Juan
GSK Investigational Site, San Juan
GSK Investigational Site, Bucharest
GSK Investigational Site, Bucharest
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Zurich
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY